Habib Yaribeygi | Molecular Pathways | Best Researcher Award
Dr. Habib Yaribeygi ,Semnan University of Medical Sciences, Iran.
Publication profile
Scopus
Googlescholar
Education and Experience
Β B.Sc. in NursingΒ β Shahid Beheshti University of Medical Sciences (Tehran, Iran), 2004
Β M.Sc. in PhysiologyΒ β Baqiyatallah University of Medical Sciences (Tehran, Iran), 2010
Β PhD in PhysiologyΒ β Baqiyatallah University of Medical Sciences (Tehran, Iran), 2017
Β Assistant Professor of Medical PhysiologyΒ β Semnan University of Medical Sciences, 2019-present
Β Founder and Head of Diabetes Research LabΒ β Semnan University of Medical Sciences, 2020-present
Β Lecturer for Medical and International Medicine StudentsΒ β Semnan University of Medical Sciences, 2019-present
Suitability For The Award
Dr. Habib Yaribeygi, an Assistant Professor of Medical Physiology and the founder of the Diabetes Research Lab at Semnan University of Medical Sciences, stands out as an exceptional candidate for the Best Researcher Award. His impressive academic background, extensive research contributions, and recognition as one of the worldβs top 2% scientists (Stanford University, 2021-2023) highlight his significant impact in the field of medical physiology, particularly regarding diabetes research.
Professional Development (
)
Awards and Honors (
)
Β Worldβs Top 2% ScientistΒ β Stanford University (2021-2023)
Β Founder and Head of Diabetes Research LabΒ β Semnan University of Medical Sciences
Β Member of European Society of AtherosclerosisΒ (2024-present)
Β GBD Senior CollaboratorΒ (2024-present)
Β Member of Biomedical Research Ethics CommitteeΒ β Semnan University of Medical Sciences (2024-present)
Publications
Β The impact of stress on body function: A reviewΒ βΒ Cited byΒ 1742 (2017)
Β Insulin resistance: Review of the underlying molecular mechanismsΒ βΒ Cited byΒ 865 (2019)
Β Molecular mechanisms linking oxidative stress and diabetes mellitusΒ βΒ Cited byΒ 606 (2020)
Β Global Burden of Cardiovascular Diseases and Risks, 1990-2022Β βΒ Cited byΒ 282 (2023)
Β A review of the molecular mechanisms of hyperglycemia-induced free radical generation leading to oxidative stressΒ βΒ Cited byΒ 249 (2019)
Β Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990β2021: a systematic analysisΒ βΒ Cited byΒ 175 (2024)
Β Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuriesΒ βΒ Cited byΒ 146 (2024)
Habib Yaribeygi | Molecular Pathways | Best Researcher Award
Β Recognized as one of theΒ Worldβs Top 2% ScientistsΒ by Stanford University (2021-2023), Dr. Yaribeygiβs research focuses on innovative treatments to improve cognitive and organ functions in diabetic patients. He is a dedicated educator, global collaborator, and passionate leader in advancing medical research for a healthier world.Β 
Β He is an influential member of numerous prestigious organizations, including theΒ European Society of AtherosclerosisΒ and theΒ Iranian Neuroscience Society. His contributions have been essential in promoting advanced diabetes treatments that target
Β His focus on international collaboration and dedication to advancing physiological research has placed him at the forefront of his field, shaping the future of diabetes management and treatment worldwide.Β 


He also leads clinical trials investigating the impact of these treatments on cognitive, renal, liver, and pancreatic functions in diabetic patients.
His research aims to provide innovative solutions for managing diabetes and preventing its complications, ultimately improving patients’ quality of life.